AML Treatment Planning | Key Questions to Ask Your Doctor

What key questions should patients ask about their AML treatment plan? Dr. Daniel Pollyea provides key advice and emphasizes the importance of sharing symptoms, while also highlighting the critical role of a care partner for support and advocacy in AML care.

Dr. Daniel Pollyea is Clinical Director of Leukemia Services in the Division of Medical Oncology, Hematologic Malignancies and Blood and Marrow Transplant at University of Colorado Cancer Center. Learn more about Dr. Pollyea, here: https://som.cuanschutz.edu/Profiles/F....

Patient Empowerment Network (PEN) is a 501(c)(3) non-profit organization. PEN’s mission is to offer trusted information to empower anyone impacted by cancer, through health equity, health literacy and shared decision-making. Subscribe now to receive the latest news on cancer treatment and research: https://powerfulpatients.org/connect